tiprankstipranks
Mirati Therapeutics (DE:26M)
FRANKFURT:26M

Mirati Therapeutics (26M) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Mirati Therapeutics’s (26M) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Mirati Therapeutics is a Buy.
Mirati Therapeutics’s (26M) 20-Day exponential moving average is 53.13, while Mirati Therapeutics’s (26M) share price is €53.3, making it a Buy.
Mirati Therapeutics’s (26M) 50-Day exponential moving average is 51.86, while Mirati Therapeutics’s (26M) share price is €53.3, making it a Buy.

Mirati Therapeutics (26M) Pivot Points

Apr 28, 2024, 01:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.30
53.30
53.30
53.30
53.30
53.30
53.30
Fibonacci
53.30
53.30
53.30
53.30
53.30
53.30
53.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mirati Therapeutics (26M) Moving Averages

Apr 28, 2024, 01:14 PM
Period
Simple
Exponential
MA5
53.32Sell
53.34Sell
MA10
53.39Sell
53.33Sell
MA20
53.18Buy
53.13Buy
MA50
52.34Buy
51.86Buy
MA100
48.22Buy
48.70Buy
MA200
41.65Buy
44.40Buy
Mirati Therapeutics’s (26M) 10-Day exponential moving average is 53.33, while Mirati Therapeutics’s (26M) share price is €53.3, making it a Sell.
Mirati Therapeutics’s (26M) 100-Day exponential moving average is 48.70, while Mirati Therapeutics’s (26M) share price is €53.3, making it a Buy.
Mirati Therapeutics’s (26M) stock price is €53.3 and Mirati Therapeutics’s (26M) 50-day simple moving average is 52.34, creating a Buy signal.
Mirati Therapeutics’s (26M) stock price is €53.3 and Mirati Therapeutics’s (26M) 100-day simple moving average is 48.22, creating a Buy signal.
Mirati Therapeutics’s (26M) stock price is €53.3 and Mirati Therapeutics’s (26M) 200-day simple moving average is 41.65, creating a Buy signal.

Mirati Therapeutics (26M) Technical Indicators

Apr 28, 2024, 01:14 PM
Name
Value
Implied Action
RSI (14)
55.58
Neutral
STOCH (9,6)
21.05
Neutral
STOCHRSI (14)
21.05
Neutral
MACD (12,26)
0.33
Buy
ADX (14)
31.41
Neutral
Williams %R
-78.95
Buy
CCI (14)
33.90
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
47.80
Neutral
ROC
0.04
Buy
Mirati Therapeutics’s (26M) Relative Strength Index (RSI) is 55.58, creating a Neutral signal.
Mirati Therapeutics’s (26M) Trend Strength Indicator (ADX) is 31.41, creating a Neutral signal.
Mirati Therapeutics’s (26M) Commodity Channel Index (CCI) is 33.90, creating a Neutral signal.
Mirati Therapeutics’s (26M) Price Rate of Change (ROC) is 0.04, creating a Buy signal.

FAQ

Is 26M a Buy, Hold, or Sell?
Based on 26M’s technical indicators, 26M is a Buy.
    What is 26M’s RSI (14)?
    26M’s RSI (14) is 55.58, which suggests 26M is a Neutral.
      What is 26M’s MACD?
      26M’s MACD is 0.33, which suggests 26M is a Buy.
        What is 26M’s 5-day moving average?
        26M’s 5-day moving average is 53.32, which suggests 26M is a Sell.
          What is 26M’s 20-day moving average?
          26M 20-day moving average is 53.18, which suggests 26M is a Buy.
            What is 26M’s 50-day moving average?
            26M’s 50-day moving average is 52.34, which suggests 26M is a Buy.
              What is 26M’s 200-day moving average?
              26M’s 200-day moving average is 41.65, which suggests 26M is a Buy.
                What is 26M’s Williams % R (14)?
                26M’s Williams % R (14) is -78.95, which suggests 26M is a Buy.
                  What is 26M’s CCI (14)?
                  26M’s CCI (14) is 33.90, which suggests 26M is a Neutral.
                    What is the share price of Mirati Therapeutics?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis